Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors

被引:3
作者
Choi, Nayeon [1 ]
Kim, Hack Jung [1 ]
Yi, Heejun [1 ]
Kim, Heejung [1 ]
Kim, Tae Hwan [1 ]
Jeong, Han-Sin [1 ]
Son, Young-Ik [1 ]
Baek, Chung-Hwan [1 ]
Oh, Dongryul [2 ]
Ahn, Yong Chan [2 ]
Chung, Man Ki [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, 81 Irwon Ro, Seoul 06351, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, 81 Irwon Ro, Seoul 06351, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2023年 / 55卷 / 04期
关键词
Oropharynx; Squamous cell carcinoma; Salvage therapy; Recurrence; Prognosis; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; SURGICAL SALVAGE; SURVIVAL; SURGERY;
D O I
10.4143/crt.2022.1046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to investigate the oncologic outcomes and prognostic factors of salvage treatments in patients with recur-rent oropharyngeal squamous cell carcinoma (OPSCC) after radiotherapy (RT)-based treatment. Materials and Methods A cancer registry was used to retrieve the records of 337 patients treated with definitive RT or concurrent chemoradiotherapy (CRT) from 2008 to 2018 at a single institution. The poor-responder group (PRG) was defined as patients with residual or recurrent disease after primary treatment, and the oncologic outcomes for each salvage treatment method were analyzed. In addition, prognostic indicators of recurrence-free survival (RFS) and overall survival (OS) were identified in patients who underwent salvage treatment. Results After initial (C)RT, the PRG comprised 71 of the 337 patients (21.1%): 18 patients had residual disease, and 53 had recur-rence after primary treatment (mean time to recurrence 19.5 months). Of these, 63 patients received salvage treatment (surgery 57.2%, re-(C)RT 23.8%, and chemotherapy 19.0%), and the salvage success rate was 47.6% at the last follow-up. The overall 2-year OS for salvage treatments was 56.4% (60.8% for the salvage surgery group and 46.2% for the salvage re-(C)RT). Salvage surgery patients with negative resection margins had better oncologic outcomes than those with close/positive resection margins. Using multivariate analyses, locoregional recurrence and residual disease after primary surgery were associated with poor outcome after salvage treatment. In Kaplan-Meier analyses, p16 status was significantly associated with OS in the initial treatment setting but not in the salvage setting. Conclusion In recurrent OPSCC after RT-based treatment, successful salvage was achieved in 56.4% patients who had undergone salvage surgery and radiation treatment. Salvage treatment methods should be selected carefully, given recurrence site as a prog-nostic factor for RFS.
引用
收藏
页码:1123 / 1133
页数:11
相关论文
共 25 条
[1]   Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 [J].
Ang, K. Kian ;
Zhang, Qiang ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Sherman, Eric J. ;
Weber, Randal S. ;
Galvin, James M. ;
Bonner, James A. ;
Harris, Jonathan ;
El-Naggar, Adel K. ;
Gillison, Maura L. ;
Jordan, Richard C. ;
Konski, Andre A. ;
Thorstad, Wade L. ;
Trotti, Andy ;
Beitler, Jonathan J. ;
Garden, Adam S. ;
Spanos, William J. ;
Yom, Sue S. ;
Axelrod, Rita S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2940-+
[2]   Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].
Ang, K. Kian ;
Harris, Jonathan ;
Wheeler, Richard ;
Weber, Randal ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Westra, William H. ;
Chung, Christine H. ;
Jordan, Richard C. ;
Lu, Charles ;
Kim, Harold ;
Axelrod, Rita ;
Silverman, C. Craig ;
Redmond, Kevin P. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35
[3]   Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: Surgery and postoperative radiotherapy versus concurrent chemoradiation [J].
Boscolo-Rizzo, Paolo ;
Stellin, Marco ;
Fuson, Roberto ;
Marchiori, Carlo ;
Gava, Alessandro ;
Da Mosto, Maria Cristina .
ORAL ONCOLOGY, 2009, 45 (11) :953-957
[4]   Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States [J].
Chaturvedi, Anil K. ;
Engels, Eric A. ;
Pfeiffer, Ruth M. ;
Hernandez, Brenda Y. ;
Xiao, Weihong ;
Kim, Esther ;
Jiang, Bo ;
Goodman, Marc T. ;
Sibug-Saber, Maria ;
Cozen, Wendy ;
Liu, Lihua ;
Lynch, Charles F. ;
Wentzensen, Nicolas ;
Jordan, Richard C. ;
Altekruse, Sean ;
Anderson, William F. ;
Rosenberg, Philip S. ;
Gillison, Maura L. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4294-4301
[5]   Changes in treatment of advanced oropharyngeal cancer, 1985-2001 [J].
Chen, Amy Y. ;
Schrag, Nicole ;
Hao, Yongping ;
Stewart, Andrew ;
Ward, Elizabeth .
LARYNGOSCOPE, 2007, 117 (01) :16-21
[6]   Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation [J].
Christopherson, Kaitlin M. ;
Moreno, Amy C. ;
Elgohari, Baher ;
Gross, Neil ;
Ferrarotto, Renata ;
Radwan Mohamed, Abdallah Sherif ;
Gunn, G. Brandon ;
Goepfert, Ryan P. ;
Mott, Frank E. ;
Shah, Shalin J. ;
Fuller, C. David ;
Reddy, Jay P. ;
Frank, Steven J. ;
Morrison, William H. ;
Phan, Jack ;
Rosenthal, David, I ;
Garden, Adam S. .
ORAL ONCOLOGY, 2021, 113
[7]   Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer [J].
Chung, Man Ki ;
Jeong, Han-Sin ;
Park, Sang Gyu ;
Jang, Jeon Yeob ;
Son, Young-Ik ;
Choi, Joon Young ;
Hyun, Seung Hyup ;
Park, Keunchil ;
Ahn, Myung-Ju ;
Ahn, Yong Chan ;
Kim, Hyung-Jin ;
Ko, Young-Hyeh ;
Baek, Chung-Hwan .
CLINICAL CANCER RESEARCH, 2009, 15 (18) :5861-5868
[8]   Oropharyngeal cancer: current understanding and management [J].
Cohan, David M. ;
Popat, Saurin ;
Kaplan, Seth E. ;
Rigual, Nestor ;
Loree, Thom ;
Hicks, Wesley L., Jr. .
CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2009, 17 (02) :88-94
[9]   Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study [J].
Culie, Dorian ;
Lisan, Quentin ;
Leroy, Charlotte ;
Modesto, Anouchka ;
Schiappa, Renaud ;
Chamorey, Emmanuel ;
Dassonville, Olivier ;
Poissonnet, Gilles ;
Guelfucci, Bruno ;
Bizeau, Alain ;
Vergez, Sebastien ;
Dupret-Bories, Agnes ;
Garrel, Renaud ;
Fakhry, Nicolas ;
Santini, Laure ;
Lallemant, Benjamin ;
Chambon, Guillaume ;
Sudaka, Anne ;
Peyrade, Frederic ;
Saada-Bouzid, Esma ;
Benezery, Karen ;
Jourdan-Soulier, Florence ;
Chapel, Francoise ;
Ramay, Anne Sophie ;
Roger, Pascal ;
Galissier, Thibault ;
Coste, Valerie ;
Lakdar, Aicha B. ;
Temam, Stephane ;
Gorphe, Phillipe ;
Guerlain, Joanne ;
Bozec, Alexandre ;
Mirghani, Haitham .
EUROPEAN JOURNAL OF CANCER, 2021, 143 :168-177
[10]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474